Symbiotec Steroids Private Limited

Symbiotec Steroids Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials and compliance.
CIN U67120MP1997PTC012314 Incorporated 18 September 1997 ROC Gwalior HQ Indore, Madhya Pradesh, India
Converted to LLP Private Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹33.33 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹35.95 Cr
Company age
29 yrs
Est. 1997
Last financials
Mar 2015
Balance sheet date

About Symbiotec Steroids Private Limited

Data last updated: 23 July 2025

Symbiotec Steroids Private Limited is a private limited company based in Indore, Madhya Pradesh, India. The company has been converted to a Limited Liability Partnership (LLP). For the latest details, refer to the successor LLP entity. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 18 September 1997, the company has been in operation for over 29 years.

Registered with ROC Gwalior under CIN U67120MP1997PTC012314.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.33 Lakh. It is led by directors Kashish Satwani and Anil Kumar Satwani.

Last AGM: 30 September 2015. Financial statements filed for year ended 31 March 2015. Office: 33 – 34 Shanti Niketan Near Bombay Hospital, Indore, Madhya Pradesh, India – 452010.

As per MCA filings, the company has satisfied charges of ₹35.95 Cr on record.

The company has been converted to a Limited Liability Partnership (LLP). For the most current information, refer to the successor LLP entity registered with MCA. The last known website on record is symbiotec.in.

Company Details of Symbiotec Steroids Private Limited
CIN U67120MP1997PTC012314
Registration Number 012314
Incorporation Date 18 September 1997
ROC Gwalior
Listing Status Unlisted
Company Status Converted to LLP
Date of Last AGM 30 September 2015
Date of Balance Sheet 31 March 2015
Key People
Kashish Satwani Director Anil Kumar Satwani Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
  • Registered Address
    33 – 34 Shanti Niketan Near Bombay Hospital, Indore, Madhya Pradesh, India – 452010
  • Industry
    Pharma, API Manufacturers
Company report
Symbiotec Steroids Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Symbiotec Steroids Private Limited report

Financials, compliance, directors, charges, ownership and filings for Symbiotec Steroids Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Board of Directors of Symbiotec Steroids Private Limited

Symbiotec Steroids Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Kashish Satwani
Also directs: Aakarshan Realinfra Llp, Satwani Holdings Llp, Azadu Commercials Llp and 5 more
Director 18 Sep 1997 28 Years 9 Months As last reported
Anil Kumar Satwani
Also directs: Aakarshan Realinfra Llp, Satwani Holdings Llp, Azadu Commercials Llp and 5 more
Director 18 Sep 1997 28 Years 9 Months As last reported
View all directors

Financials of Symbiotec Steroids Private Limited FY 2015 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Symbiotec Steroids Private Limited

Open charges
₹0
Satisfied charges
₹35.95 Cr
Breakdown by lending institutions
State Bank of India₹35.50 Cr
Idbi Bank Ltd.₹0.45 Cr
Latest charge details
DateLenderAmountStatus
22 Nov 2005 State Bank of India ₹35.5 Cr Satisfied
30 Mar 2000 Idbi Bank Ltd. ₹45 Lakh Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Symbiotec Steroids Private Limited

View historical data on people associated with Symbiotec Steroids Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Symbiotec Steroids Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Symbiotec Steroids Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Symbiotec Steroids Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Symbiotec Steroids Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Symbiotec Steroids Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Symbiotec Steroids Private Limited

MSME Payment Delays by Symbiotec Steroids Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Symbiotec Steroids Private Limited

Subsidiaries & Group Companies of Symbiotec Steroids Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Symbiotec Steroids Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Symbiotec Steroids Private Limited

MCA Filings & Documents of Symbiotec Steroids Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Symbiotec Steroids Private Limited

Charges
05 Feb 2016
A charge registered on 22 Nov 2005 via Charge ID 80008547 with State Bank Of India was fully satisfied on 05 Feb 2016.
Activity
30 Sep 2015
Symbiotec Steroids Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
Activity
31 Mar 2015
Symbiotec Steroids Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Gwalior.
Charges
23 Jun 2007
A charge with State Bank Of India of Rs. 3,550.00 Lakh registered on 22 Nov 2005 with Charge ID 80008547 was modified on 23 Jun 2007.
Charges
22 Nov 2005
A charge with State Bank Of India amounted to Rs. 3,550.00 Lakh with Charge ID 80008547 was registered on 22 Nov 2005.
Charges
16 Aug 2002
A charge registered on 30 Mar 2000 via Charge ID 90208622 with Idbi Bank Ltd. was fully satisfied on 16 Aug 2002.

Recent News on Symbiotec Steroids Private Limited

Frequently Asked Questions about Symbiotec Steroids Private Limited

Symbiotec Steroids Private Limited has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Symbiotec Steroids Private Limited is a former company now converted to LLP, previously operating as a private limited company in the pharma sector based in Indore, Madhya Pradesh, India. It was incorporated on 18 September 1997 and is registered under CIN U67120MP1997PTC012314. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Symbiotec Steroids Private Limited is U67120MP1997PTC012314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The current directors of Symbiotec Steroids Private Limited are:

The primary industry of Symbiotec Steroids Private Limited is pharma. The company specifically operates in api manufacturers.

Symbiotec Steroids Private Limited was incorporated on 18 September 1997. Registered with ROC Gwalior.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available